Issue |
E3S Web Conf.
Volume 175, 2020
XIII International Scientific and Practical Conference “State and Prospects for the Development of Agribusiness – INTERAGROMASH 2020”
|
|
---|---|---|
Article Number | 08012 | |
Number of page(s) | 10 | |
Section | Food Process Engineering and Technology | |
DOI | https://doi.org/10.1051/e3sconf/202017508012 | |
Published online | 29 June 2020 |
Development of technology for a fermented drink with cancer protective properties
1
Saint Petersburg National Research University of Information Technology, Mechanics and Optics (ITMO University), 191002, Lomonosova str. 9, Saint Petersburg, Russia
2
Saint-Petersburg State Institute of Technology, 190013, Moskovsky pr., 26, Saint-Petersburg, Russia
* Corresponding author: tnbelyakova517@gmail.com
Some plant sources of biologically active substances particularly cruciferous vegetables, both in native form and as extracts, display effects towards carcinogenesis that make these food sources cancer protective and recurrence preventive agents. In the currently developing tendency towards functional foodstuffs like dairy products targeted at nutritional-dependent diseases, development of a dairy beverage containing sulforaphane deserves attention. Creating a recipe for such a product includes: selecting a plant sulforaphane source, testing its compatibility with the milk base, choosing the addition dosage and methods and experimental beverage preparation. In pursuit of these goals in the study, firstly, turnip (Brassica rapa l.) root, an affordable sulforaphane provider, was chosen. Glucoraphanin content in various turnip varieties was determined and the Golden Ball variety selected. Sulforaphane was introduced to milk in turnip purée and aqueous extract forms. The effect of purée/extract dosage on milk fermentation process and the final producťs quality parameters was investigated. Both purée and extract containing products had a pleasant taste with a vegetable note and uniform consistency. Sulforaphane content in 200 g beverage servings was (23.5 ± 2.1) mg and (29.5 ± 0.5) mg (extract), both values approximately one tenth of therapeutic dose estimates, which is enough for cancer preventive purposes.
© The Authors, published by EDP Sciences, 2020
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.